Post-approval studies (Phase 4)Ended earlyNCT05075538
What this trial is testing
COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2
Who this might be right for
Cancer
Jules Bordet Institute 152
Showing 20 of 613 results